Contact us  Chinese
Shanghai Newsummit Biopharma Co.Ltd
business solutions
core business

Core Business Model

Key Products

core competitive advantages


Core Competitive Advantages
& Industry Status


Newsummit CRO Service Network

company profile

We are a leading China-based new drug development process solutions provider. Our main business is to provide professional technology service for new drug research and development. Through collabo-ration with five state high tech clusters and integration of upstream and downstream suppliers, we establish the Platform of Chain R&D (PCRD) by offering a full range of services for new drug R&D.

We set up a modularized, standardized and industrialized pipeline system to provide Good Research and Development Practices (GRDP) for new drug R&D, including: pre-clinical new drug research service focusing on pharmacology and toxicology research (IND-CRO);phase I, II and III clinical studies and pilot-scale up studies (NDA-CRO); international multi-center clinical research service and international clinical Phase I/II studies after completing SFDA II A clinical studies(FDA/EMEA-CRO); research and registration services on medical devices, diagnostics, medical equipment; during their new drug development process, our value-added services will provide clients with opportunities to access additional funding, such as government research grants and private investment......

news
·  The IND Sumbission of of Biological New Drug (Category I)"ZD55-IL-...
2015-05-29
·  The Inauguration of National Science and Technology Enterprise Inc...
2015-03-09
·  Shanghai Newsummit Biopharma Group Co.Ltd attendance to BIO in 201...
2014-06-26
·  The eighth BIO China Industry Conference...
2014-06-20
·  Prime Minister Li's visit to Britain to witness the signing in 201...
2014-06-15
 
Address: 2F,No.780,Cailun Road,Zhangjiang High Technology Park,Shanghai City,China
Tel: +86-21-50798788-8032
Fax: +86-21-50798788-8088
Website: http://www.newsummitbio.com/
Email: ibd_information@newsummitbio.com
 
link

2010bioeco General Assembly

U.S. bio

Copyright(C)2016,Shanghai Newsummit Biopharma Co.Ltd All Rights Reserved.  Supported by Information Center